{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T18:05:39Z","timestamp":1787853939614,"version":"build-2784847793"},"reference-count":40,"publisher":"American Association for Cancer Research (AACR)","issue":"5","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>No chemoprevention strategies have been proven effective for lung cancer.<\/jats:p>\n               <jats:p>We evaluated the effect of 13-cis retinoic acid (13-cis RA), with or without \u03b1 tocopherol, as a lung cancer chemoprevention agent in a phase II randomized controlled clinical trial of adult subjects at high risk for lung cancer as defined by the presence of sputum atypia, history of smoking, and airflow obstruction, or a prior surgically cured nonsmall cell lung cancer (disease free, &amp;gt;3 years). Subjects were randomly assigned to receive either 13-cis RA, 13-cis RA plus \u03b1 tocopherol (13-cis RA\/\u03b1 toco) or observation for 12 months.<\/jats:p>\n               <jats:p>Outcome measures are derived from histologic evaluation of bronchial biopsy specimens obtained by bronchoscopy at baseline and follow-up. The primary outcome measure is treatment \u201cfailure\u201d defined as histologic progression (any increase in the maximum histologic score) or failure to return for follow-up bronchoscopy.<\/jats:p>\n               <jats:p>Seventy-five subjects were randomized (27\/22\/26 to obervations\/13-cis RA\/13-cis RA\/\u03b1 toco); 59 completed the trial; 55 had both baseline and follow-up bronchoscopy. The risk of treatment failure was 55.6% (15 of 27) and 50% (24 of 48) in the observation and combined (13 cis RA plus 13 cis RA\/\u03b1 toco) treatment arms, respectively (odds ratio adjusted for baseline histology, 0.97; 95% confidence interval, 0.36-2.66; P = 0.95). Among subjects with complete histology data, maximum histology score in the observation arm increased by 0.37 units and by 0.03 units in the treated arms (difference adjusted for baseline, \u22120.18; 95% confidence interval, \u22121.16 to 0.81; P = 0.72). Similar (nonsignificant) results were observed for treatment effects on endobronchial proliferation as assessed by Ki-67 immunolabeling.<\/jats:p>\n               <jats:p>Twelve-month treatment with 13-cis RA produced nonsignificant changes in bronchial histology, consistent with results in other trials. Agents advancing to phase III randomized trials should produce greater histologic changes. The addition of \u03b1 tocopherol did not affect toxicity.<\/jats:p>","DOI":"10.1158\/1940-6207.capr-08-0136","type":"journal-article","created":{"date-parts":[[2009,4,29]],"date-time":"2009-04-29T02:03:51Z","timestamp":1240970631000},"page":"440-449","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["A Randomized Phase II Chemoprevention Trial of 13-CIS Retinoic Acid with Or without \u03b1 Tocopherol or Observation in Subjects at High Risk for Lung Cancer"],"prefix":"10.1158","volume":"2","author":[{"given":"Karen","family":"Kelly","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Medical Oncology, Departments of 2Biostatistics and 3Pathology, 4Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado at Denver, 5Denver Veterans Affairs Medical Center, and 6HealthOne, University of Colorado Cancer Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kittelson","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Medical Oncology, Departments of 2Biostatistics and 3Pathology, 4Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado at Denver, 5Denver Veterans Affairs Medical Center, and 6HealthOne, University of Colorado Cancer Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbur A.","family":"Franklin","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Medical Oncology, Departments of 2Biostatistics and 3Pathology, 4Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado at Denver, 5Denver Veterans Affairs Medical Center, and 6HealthOne, University of Colorado Cancer Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy C.","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Medical Oncology, Departments of 2Biostatistics and 3Pathology, 4Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado at Denver, 5Denver Veterans Affairs Medical Center, and 6HealthOne, University of Colorado Cancer Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine E.","family":"Klein","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Medical Oncology, Departments of 2Biostatistics and 3Pathology, 4Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado at Denver, 5Denver Veterans Affairs Medical Center, and 6HealthOne, University of Colorado Cancer Center, Denver, Colorado"},{"name":"Authors' Affiliations:\u20081Division of Medical Oncology, Departments of 2Biostatistics and 3Pathology, 4Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado at Denver, 5Denver Veterans Affairs Medical Center, and 6HealthOne, University of Colorado Cancer Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Keith","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Medical Oncology, Departments of 2Biostatistics and 3Pathology, 4Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado at Denver, 5Denver Veterans Affairs Medical Center, and 6HealthOne, University of Colorado Cancer Center, Denver, Colorado"},{"name":"Authors' Affiliations:\u20081Division of Medical Oncology, Departments of 2Biostatistics and 3Pathology, 4Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado at Denver, 5Denver Veterans Affairs Medical Center, and 6HealthOne, University of Colorado Cancer Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward C.","family":"Dempsey","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Medical Oncology, Departments of 2Biostatistics and 3Pathology, 4Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado at Denver, 5Denver Veterans Affairs Medical Center, and 6HealthOne, University of Colorado Cancer Center, Denver, Colorado"},{"name":"Authors' Affiliations:\u20081Division of Medical Oncology, Departments of 2Biostatistics and 3Pathology, 4Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado at Denver, 5Denver Veterans Affairs Medical Center, and 6HealthOne, University of Colorado Cancer Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Lewis","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Medical Oncology, Departments of 2Biostatistics and 3Pathology, 4Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado at Denver, 5Denver Veterans Affairs Medical Center, and 6HealthOne, University of Colorado Cancer Center, Denver, Colorado"},{"name":"Authors' Affiliations:\u20081Division of Medical Oncology, Departments of 2Biostatistics and 3Pathology, 4Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado at Denver, 5Denver Veterans Affairs Medical Center, and 6HealthOne, University of Colorado Cancer Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary K.","family":"Jackson","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Medical Oncology, Departments of 2Biostatistics and 3Pathology, 4Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado at Denver, 5Denver Veterans Affairs Medical Center, and 6HealthOne, University of Colorado Cancer Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred R.","family":"Hirsch","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Medical Oncology, Departments of 2Biostatistics and 3Pathology, 4Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado at Denver, 5Denver Veterans Affairs Medical Center, and 6HealthOne, University of Colorado Cancer Center, Denver, Colorado"},{"name":"Authors' Affiliations:\u20081Division of Medical Oncology, Departments of 2Biostatistics and 3Pathology, 4Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado at Denver, 5Denver Veterans Affairs Medical Center, and 6HealthOne, University of Colorado Cancer Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Bunn","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Medical Oncology, Departments of 2Biostatistics and 3Pathology, 4Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado at Denver, 5Denver Veterans Affairs Medical Center, and 6HealthOne, University of Colorado Cancer Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"York E.","family":"Miller","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Medical Oncology, Departments of 2Biostatistics and 3Pathology, 4Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado at Denver, 5Denver Veterans Affairs Medical Center, and 6HealthOne, University of Colorado Cancer Center, Denver, Colorado"},{"name":"Authors' Affiliations:\u20081Division of Medical Oncology, Departments of 2Biostatistics and 3Pathology, 4Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado at Denver, 5Denver Veterans Affairs Medical Center, and 6HealthOne, University of Colorado Cancer Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2009,5,5]]},"reference":[{"key":"2022060815505290500_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"2022060815505290500_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/0003-4819-142-4-200502150-00005","article-title":"The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial","volume":"142","author":"Anthonisen","year":"2005","journal-title":"Ann Intern Med"},{"key":"2022060815505290500_bib3","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/(SICI)1097-0142(19960901)78:5<1004::AID-CNCR10>3.0.CO;2-6","article-title":"Lung carcinoma in former smokers","volume":"78","author":"Tong","year":"1996","journal-title":"Cancer"},{"key":"2022060815505290500_bib4","first-page":"1332","article-title":"Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids)","volume":"35","author":"Sporn","year":"1976","journal-title":"Fed Proc"},{"key":"2022060815505290500_bib5","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","article-title":"Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study","volume":"97","author":"Fisher","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"2022060815505290500_bib6","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"key":"2022060815505290500_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer","volume":"349","author":"Thompson","year":"2003","journal-title":"N Engl J Med"},{"key":"2022060815505290500_bib8","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJMoa012015","article-title":"Primary chemoprevention of familial adenomatous polyposis with sulindac","volume":"346","author":"Giardiello","year":"2002","journal-title":"N Engl J Med"},{"key":"2022060815505290500_bib9","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJM200006293422603","article-title":"The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis","volume":"342","author":"Steinbach","year":"2000","journal-title":"N Engl J Med"},{"key":"2022060815505290500_bib10","first-page":"78","article-title":"Effects of 13-CIS retinoids on premalignant and malignant cells of lung origin","volume":"26","author":"Saccomanno","year":"1982","journal-title":"Acta Cytol"},{"key":"2022060815505290500_bib11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1365-2559.2001.01078.x","article-title":"Reproducibility of the WHO\/IASLC grading system for pre-invasive squamous lesions of the bronchus: a study of inter-observer and intra-observer variation","volume":"38","author":"Nicholson","year":"2001","journal-title":"Histopathology"},{"key":"2022060815505290500_bib12","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1056\/NEJM199605023341802","article-title":"Effects of a combination of \u03b2 carotene and vitamin A on lung cancer and cardiovascular disease","volume":"334","author":"Omenn","year":"1996","journal-title":"N Engl J Med"},{"key":"2022060815505290500_bib13","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199404143301501","article-title":"The effect of vitamin E and \u03b2 carotene on the incidence of lung cancer and other cancers in male smokers.","volume":"330","author":"The \u03b1-Tocopherol, \u03b2 Carotene Cancer Prevention Study Group.","year":"1994","journal-title":"N Engl J Med"},{"key":"2022060815505290500_bib14","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1158\/1055-9965.EPI-06-0316","article-title":"Lung cancer chemoprevention: a randomized, double-blind trial in Linxian, China","volume":"15","author":"Kamangar","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060815505290500_bib15","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/jnci\/93.8.605","article-title":"Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer","volume":"93","author":"Lippman","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"2022060815505290500_bib16","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/jnci\/92.12.977","article-title":"EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups","volume":"92","author":"van Zandwijk","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"2022060815505290500_bib17","first-page":"314","article-title":"Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development","volume":"8","author":"O'Shaughnessy","year":"1989","journal-title":"Clin Cancer Res"},{"key":"2022060815505290500_bib18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/sim.4780080407","article-title":"Surrogate endpoints in clinical trials: definition and operational criteria","volume":"8","author":"Prentice","year":"2002","journal-title":"Stat Med"},{"key":"2022060815505290500_bib19","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/sim.1780","article-title":"Does the Prentice criterion validate surrogate endpoints?","volume":"23","author":"Berger","year":"2004","journal-title":"Stat Med"},{"key":"2022060815505290500_bib20","doi-asserted-by":"crossref","first-page":"1431S","DOI":"10.1093\/ajcn\/62.6.1431S","article-title":"\u03b2-Carotene, vitamin A, lung cancer chemoprevention: results of an intermediate endpoint study","volume":"62","author":"McLarty","year":"1995","journal-title":"Am J Clin Nutr"},{"key":"2022060815505290500_bib21","first-page":"2973","article-title":"N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium","volume":"6","author":"Kurie","year":"2000","journal-title":"Clin Cancer Res"},{"key":"2022060815505290500_bib22","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/jnci\/94.13.1001","article-title":"A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia","volume":"94","author":"Lam","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"2022060815505290500_bib23","doi-asserted-by":"crossref","first-page":"6502","DOI":"10.1158\/1078-0432.CCR-04-0686","article-title":"A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium","volume":"10","author":"Lam","year":"2004","journal-title":"Clin Cancer Res"},{"key":"2022060815505290500_bib24","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1164\/rccm.200612-1770OC","article-title":"The influence of fluticasone inhalation on markers of carcinogenesis in bronchial epithelium","volume":"175","author":"van den Berg","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2022060815505290500_bib25","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1158\/1078-0432.CCR-06-1104","article-title":"Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer-a plan to move forward","volume":"12","author":"Kelloff","year":"2006","journal-title":"Clin Cancer Res"},{"key":"2022060815505290500_bib26","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/jnci\/93.14.1042","article-title":"Lung epithelial proliferation: a biomarker for chemoprevention trials?","volume":"93","author":"Szabo","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"2022060815505290500_bib27","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/jnci\/93.14.1081","article-title":"Long-term impact of smoking on lung epithelial proliferation in current and former smokers","volume":"93","author":"Lee","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"2022060815505290500_bib28","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1158\/1078-0432.CCR-05-1440","article-title":"Celecoxib decreases Ki-67 proliferative index in active smokers","volume":"12","author":"Mao","year":"2006","journal-title":"Clin Cancer Res"},{"key":"2022060815505290500_bib29","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/jnci\/djm205","article-title":"Proliferative changes in the bronchial epithelium of former smokers treated with retinoids","volume":"99","author":"Hittelman","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"2022060815505290500_bib30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/jnci\/91.8.691","article-title":"Sex-related differences in bronchial epithelial changes associated with tobacco smoking","volume":"91","author":"Lam","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"2022060815505290500_bib31","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1158\/1055-9965.EPI-07-0220","article-title":"Bronchial epithelial Ki-67 index is related to histology, smoking, and gender, but not lung cancer or chronic obstructive pulmonary disease","volume":"16","author":"Miller","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060815505290500_bib32","first-page":"1307","article-title":"Retinoid inhibition of experimental lingual carcinogenesis: ultrastructural observations","volume":"65","author":"Shklar","year":"1980","journal-title":"J Natl Cancer Inst"},{"key":"2022060815505290500_bib33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199301073280103","article-title":"Comparison of low-dose isotretinoin with \u03b2 carotene to prevent oral carcinogenesis","volume":"328","author":"Lippman","year":"1993","journal-title":"N Engl J Med"},{"key":"2022060815505290500_bib34","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJM198612113152401","article-title":"13-cis-retinoic acid in the treatment of oral leukoplakia","volume":"315","author":"Hong","year":"1986","journal-title":"N Engl J.Med"},{"key":"2022060815505290500_bib35","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/jnci\/91.15.1317","article-title":"Nuclear retinoid acid receptor \u03b2 in bronchial epithelium of smokers before and during chemoprevention","volume":"91","author":"Xu","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"2022060815505290500_bib36","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jnci\/95.3.206","article-title":"Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-\u03b2 expression in the bronchial epithelium: results from a randomized placebo-controlled trial","volume":"95","author":"Kurie","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"2022060815505290500_bib37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/A:1008209525671","article-title":"Phase I trial of \u03b1-tocopherol effects on 13-cis-retinoic acid toxicity","volume":"8","author":"Dimery","year":"1997","journal-title":"Ann Oncol"},{"key":"2022060815505290500_bib38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00944177","article-title":"Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria","volume":"10","author":"Green","year":"1992","journal-title":"Invest New Drugs"},{"key":"2022060815505290500_bib39","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/jnci\/93.18.1385","article-title":"Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study","volume":"93","author":"Hirsch","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"2022060815505290500_bib40","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1158\/1078-0432.CCR-05-2291","article-title":"Analysis of c-ErbB1\/epidermal growth factor receptor and c-ErbB2\/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer","volume":"12","author":"Merrick","year":"2006","journal-title":"Clin Cancer Res"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/2\/5\/440\/1732138\/440.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/2\/5\/440\/1732138\/440.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T16:37:09Z","timestamp":1654706229000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/2\/5\/440\/47845\/A-Randomized-Phase-II-Chemoprevention-Trial-of-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,1]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2009,5,5]]},"published-print":{"date-parts":[[2009,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-08-0136","relation":{},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,1]]}}}